Article

Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adults

2022-07-29

Abstract excerpt

<h4>Summary</h4> The recent outbreak of monkeypox (MPXV) outside its endemic boundaries has attracted global attention and prompted world leaders to reserve millions of doses of the only approved third-generation smallpox/MPXV vaccine, Jynneos, which is based on the highly attenuated modified vaccinia Ankara (MVA) vector. We previously developed COH04S1, a multiantigen SARS-CoV-2 vaccine built on a synthetic MVA (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3d938475-feec-56b2-8a9c-740424c54816
DOI: 10.1101/2022.07.26.22277958

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adultsDOI 10.1101/2022.07.26.22277958Read

Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesSemantic proximity Read

Comprehensive Profiling of Monkeypox Virus Antigens Identifies Potent Targets for Next-Generation mRNA Vaccine DevelopmentSemantic proximity Read

Mpox vaccine and infection-driven human immune signaturesSemantic proximity Read

JYNNEOS VS. ACAM2000: A CRITICAL REVIEW OF THE SAFETY, EFFICACY AND REAL-WORLD EFFECTIVENESS OF MONKEYPOX VACCINESSemantic proximity Read

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformSemantic proximity Read

A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus diseaseSemantic proximity Read

Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infectionsSemantic proximity Read

A cocktail vaccine with monkeypox virus antigens confers protection without selecting mutations in potential immune evasion genes in the vaccinia WR strain challenge.Semantic proximity Read

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformSemantic proximity Read

A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infectionSemantic proximity Read

A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challengeSemantic proximity Read

Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineSemantic proximity Read